Live Breaking News & Updates on Co National Principal Investigator

Stay updated with breaking news from Co national principal investigator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial

Contego Medical Announces One-Year Outcomes From the Performance II Carotid Stent Trial
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

William Gray , Stacy Enxing Seng , Division Of Cardiovascular Diseases , Product Service , Centers For Medicare Medicaid Services , National Principal Investigator , Contego Medical Inc , Main Line Health , Medical Announces One Year Outcomes From , Medical Inc , Vascular Interventional Advances , System Chief , Cardiovascular Diseases , Co National Principal Investigator , Contego Medical , Medicaid Services , Ravish Sachar , Operating Partner , Lightstone Ventures , Integrated Embolic Protection ,

PERFORMANCE II Carotid Stent Trial One-Year Outcomes Released at VIVA23

Contego Medical Inc. announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual VIVA (Vascular InterVentional Advances), VIVA 23, being held Oct. 30-Nov. 2 in Las Vegas, NV. The PERFORMANCE II is a prospective, multicenter study evaluating the safety and effectiveness of the Neuroguard IEP System in 305 patients at 40 clinical sites. ....

Stacy Enxing Seng , William Gray , Las Vegas , Contego Medical Inc , Centers For Medicare Medicaid Services , Viva Foundation Oct , Division Of Cardiovascular Diseases , Main Line Health , National Principal Investigator , Contego Medical , Vascular Interventional Advances , Aviva Foundation , System Chief , Cardiovascular Diseases , Co National Principal Investigator , Medicaid Services , Ravish Sachar , Operating Partner , Lightstone Ventures ,

CONTEGO MEDICAL ANNOUNCES START OF ENROLLMENT IN PERFORMANCE III DIRECT TRANSCAROTID ACCESS STENTING TRIAL

RALEIGH, N.C., Oct. 6, 2023 /PRNewswire/ Contego Medical Inc., a company dedicated to improving patient outcomes and procedural efficiency in t. ....

Robert Mendes , Stacy Enxing Seng , Sean Lyden , Department Of Vascular Surgery At Cleveland Clinic , Contego Medical Inc , National Principal Investigator , Prnewswire Contego Medical Inc , Drug Administration , Contego Medical , University Of North Carolina Rex Hospital , Medical Inc , Direct System , Investigational Device Exemption , Ravish Sachar , Operating Partner , Lightstone Ventures , Vascular Surgery , Cleveland Clinic , Co National Principal Investigator , North Carolina Rex Hospital , Integrated Embolic Protection ,

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation fo ....

United States , University Of Wisconsin , Peter Altman , Carl Pepine , Miranda Peto , David Mcclung , Statistical Data Analysis Center , Exchange Commission On , University Of Florida At Gainesville , National Principal Investigator , Biocardia Inc , National Principal Investigators , Maryland Stem Cell Research Fund , Cardiamp Cell Therapy Program , Cell Therapy , Heart Failure , Breakthrough Designation , Six Minute Walk Test , Co National Principal Investigators , Amish Raval , Co National Principal Investigator , Biocardia President , Principal Investigators , Executive Steering , Upcoming Milestones , Heart Failure Phase ,

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial - BioCardia (NASDAQ:BCDA)

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today ....

United States , University Of Wisconsin , Carl Pepine , David Mcclung , Miranda Peto , Peter Altman , Cardiamp Cell Therapy Program , National Principal Investigators , University Of Florida At Gainesville , Biocardia Inc , National Principal Investigator , Statistical Data Analysis Center , Exchange Commission On , Maryland Stem Cell Research Fund , Cell Therapy , Heart Failure , Breakthrough Designation , Six Minute Walk Test , Co National Principal Investigators , Amish Raval , Co National Principal Investigator , Biocardia President , Principal Investigators , Executive Steering , Upcoming Milestones , Heart Failure Phase ,